文献
J-GLOBAL ID:201702234509708166
整理番号:17A0998266
新規長時間作用型抗マラリアDSM265の安全性,忍容性,薬物動態,および活性:2部First in Human相1a/1b無作為化試験【Powered by NICT】
Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study
著者 (18件):
McCarthy James S
(QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia)
,
McCarthy James S
(Q-Pharm Pty Ltd, Herston, QLD, Australia)
,
Lotharius Julie
(Medicines for Malaria Venture, Geneva, Switzerland)
,
Rueckle Thomas
(Medicines for Malaria Venture, Geneva, Switzerland)
,
Chalon Stephan
(Medicines for Malaria Venture, Geneva, Switzerland)
,
Phillips Margaret A
(University of Texas Southwestern Medical Center, Dallas, TX, USA)
,
Elliott Suzanne
(Q-Pharm Pty Ltd, Herston, QLD, Australia)
,
Sekuloski Silvana
(QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia)
,
Griffin Paul
(Q-Pharm Pty Ltd, Herston, QLD, Australia)
,
Ng Caroline L
(Columbia University, New York, NY, USA)
,
Fidock David A
(Columbia University, New York, NY, USA)
,
Marquart Louise
(QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia)
,
Williams Noelle S
(University of Texas Southwestern Medical Center, Dallas, TX, USA)
,
Gobeau Nathalie
(Medicines for Malaria Venture, Geneva, Switzerland)
,
Bebrevska Lidiya
(Medicines for Malaria Venture, Geneva, Switzerland)
,
Rosario Maria
(Takeda Development Center Americas, Inc, Cambridge, MA, USA)
,
Marsh Kennan
(AbbVie, North Chicago, IL, USA)
,
Mohrle Jorg J
(Medicines for Malaria Venture, Geneva, Switzerland)
資料名:
Lancet Infectious Diseases
(Lancet Infectious Diseases)
巻:
17
号:
6
ページ:
626-635
発行年:
2017年
JST資料番号:
W3107A
ISSN:
1473-3099
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)